Correlation Between Summit Therapeutics and Prime Medicine,

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Prime Medicine, Common, you can compare the effects of market volatilities on Summit Therapeutics and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Prime Medicine,.

Diversification Opportunities for Summit Therapeutics and Prime Medicine,

0.62

Correlation Coefficient

Summit Therapeutics  Prime Medicine,

Poor diversification

The 3 months correlation between Summit and Prime is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Prime Medicine, go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Prime Medicine,

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.48 times more return on investment than Prime Medicine,. However, Summit Therapeutics is 1.48 times more volatile than Prime Medicine, Common. It trades about 0.12 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.08 per unit of risk. If you would invest  814.00  in Summit Therapeutics PLC on September 27, 2024 and sell it today you would earn a total of  1,086  from holding Summit Therapeutics PLC or generate 133.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Prime Medicine, Common

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Prime Medicine, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.

Pair Trading with Summit Therapeutics and Prime Medicine,

The main advantage of trading using opposite Summit Therapeutics and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.

The idea behind Summit Therapeutics PLC and Prime Medicine, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.